Trial Profile
A french multicentre retrospective analysis, to assess the long term efficacy of anakinra, in patients with Schnitzler's Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Schnitzler syndrome
- Focus Therapeutic Use
- 31 Mar 2015 Study title not official.
- 30 Mar 2015 New trial record